Related Experiment Video
Updated: Sep 29, 2025
06:07
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.7K
Monitoring Methionine Decarboxylase by a Supramolecular Tandem Assay
Zhe Zheng1, Siying Ren1, Wen-Chao Geng2
1School of Chemical Engineering & Technology, China University of Mining and Technology, Xuzhou, Jiangsu, P. R. China.
Chemistry, an Asian Journal
|March 25, 2022
Summary
We developed a new assay to directly measure methionine decarboxylase (MetDC) activity, crucial for cancer therapy. This method offers a simpler, more accurate way to track enzyme function and screen for potential drugs.
Area of Science:
- Biochemistry
- Enzymology
- Cancer Biology
Background:
- Methionine is an essential amino acid vital for numerous physiological and pathological processes.
- Methionine starvation, induced by methionine decarboxylase (MetDC) degradation, is an emerging cancer treatment strategy.
- Current methods for monitoring MetDC activity are indirect, complex, and lack accuracy.
Purpose of the Study:
- To develop a facile and direct assay for real-time monitoring of MetDC activity.
- To establish a reliable method for screening MetDC inhibitors for cancer therapy.
Main Methods:
- A supramolecular tandem assay (STA) was designed utilizing cucurbit[7]uril and acridine orange.
- The assay enables direct and real-time detection of MetDC enzymatic activity.
- The method was validated for its capability in inhibitor screening.
Main Results:
- The developed STA provides a straightforward and user-friendly approach to quantify MetDC activity.
- This assay offers improved accuracy and anti-interference compared to existing colorimetric methods.
- The STA successfully demonstrated its utility in screening potential inhibitors.
Conclusions:
- The supramolecular tandem assay offers a significant advancement for monitoring MetDC activity.
- This method facilitates direct, real-time enzymatic detection and inhibitor screening for cancer research.
- The assay holds promise for developing novel cancer therapeutics targeting methionine metabolism.
